Clofarabine Patent Expiration
Clofarabine is Used for treating pediatric patients aged 1 to 21 years with relapsed or refractory acute lymphoblastic leukemia. It was first introduced by Genzyme Corp
Clofarabine Patents
Given below is the list of patents protecting Clofarabine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Clolar |
US5661136 (Pediatric) | 2-halo-2'-fluoro ARA adenosines as antinoplastic agents |
Jul 14, 2018
(Expired) | Genzyme |
| Clolar | US5661136 | 2-halo-2'-fluoro ARA adenosines as antinoplastic agents |
Jan 14, 2018
(Expired) | Genzyme |
Clofarabine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List